E-mail

E-mail a Wiley Online Library Link

Christopher Bishop, Jessica A. George, William Buchta, Adam A. Goldenberg, Mohamed Mohamed, Sando O. Dickinson, Satie Eissa and Karen L. Eskow Jaunarajs Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats European Journal of Neuroscience 36

Version of Record online: 5 JUL 2012 | DOI: 10.1111/j.1460-9568.2012.08202.x

Thumbnail image of graphical abstract

Long-term l-DOPA replacement therapy in Parkinson’s disease often leads to the development of l-DOPA-induced dyskinesia. Growing evidence suggests that serotonin receptors may constitute therapeutic targets for the reduction of these abnormal involuntary movements. The current work demonstrates that serotonin transporter inhibition can also attenuate l-DOPA-induced dyskinesia without affecting l-DOPA efficacy.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH